Drug Information

Drug General Information
Drug ID
D04TWX
Former ID
DNC013460
Drug Name
(R)-3-(4-propylmorpholin-2-yl)phenol
Drug Type
Small molecular drug
Indication Discovery agent Investigative [529128]
Formula
C13H19NO2
Canonical SMILES
CCCN1CCOC(C1)C2=CC(=CC=C2)O
InChI
1S/C13H19NO2/c1-2-6-14-7-8-16-13(10-14)11-4-3-5-12(15)9-11/h3-5,9,13,15H,2,6-8,10H2,1H3/t13-/m0/s1
InChIKey
WYEGTIGJSHGEID-ZDUSSCGKSA-N
PubChem Compound ID
9794475
Target and Pathway
Target(s) 5-hydroxytryptamine 2A receptor Target Info Inhibitor [529128]
KEGG Pathway Calcium signaling pathway
Neuroactive ligand-receptor interaction
Gap junction
Serotonergic synapse
Inflammatory mediator regulation of TRP channels
PANTHER Pathway 5HT2 type receptor mediated signaling pathway
Reactome Serotonin receptors
G alpha (q) signalling events
WikiPathways Serotonin Receptor 2 and STAT3 Signaling
Serotonin Receptor 2 and ELK-SRF/GATA4 signaling
SIDS Susceptibility Pathways
Monoamine GPCRs
GPCRs, Class A Rhodopsin-like
Gastrin-CREB signalling pathway via PKC and MAPK
GPCR ligand binding
GPCR downstream signaling
GPCRs, Other
References
Ref 529128Bioorg Med Chem Lett. 2007 Dec 15;17(24):6691-6. Epub 2007 Oct 22.Design and synthesis of a functionally selective D3 agonist and its in vivo delivery via the intranasal route.
Ref 529128Bioorg Med Chem Lett. 2007 Dec 15;17(24):6691-6. Epub 2007 Oct 22.Design and synthesis of a functionally selective D3 agonist and its in vivo delivery via the intranasal route.